Inhibikase Therapeutics (IKT) Return on Sales [ROS] (2020 - 2026)
Inhibikase Therapeutics' Return on Sales [ROS] was -2006393700.00% in Q3 2024, down 2006387706.62 percentage points from -5993.38% a year earlier and down 2006369814.95 percentage points from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For FY2023, Return on Sales [ROS] at Inhibikase Therapeutics came in at -7711.98%, up 6974.19 percentage points from FY2022.
- Return on Sales [ROS] shows a three-year change of -7308.46 percentage points (FY2020 to FY2023).
- In earlier years, Return on Sales [ROS] was -14686.17% in FY2022 (-14209.94 pp), -476.23% in FY2021 (-72.71 pp) and -403.52% in FY2020.
- The Q3 2024 figure marks the lowest quarterly Return on Sales [ROS] in data going back to Q1 2020.
- Compared with a year earlier, Return on Sales [ROS] has declined for four straight quarters, with an average year-over-year change of -305797792.22 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2022 (a gain of 252514.77 percentage points); the worst was Q3 2024 (a drop of 2006387706.62 percentage points).
- Per Business Quant data, IKT's Return on Sales [ROS] in the three quarters before Q3 2024 was -23885.05% (Q2 2024), -10285.34% (Q1 2024) and -440356600.00% (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | -1,261.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,261.78% |
| Jun 30, 2026 | -1,442.08% |
| Mar 31, 2026 | -1,221.15% |
| Dec 31, 2025 | -1,324.49% |
| Sep 30, 2025 | -1,521.86% |
| Jun 30, 2025 | -1,181.59% |
| Mar 31, 2025 | -1,588.00% |
| Sep 30, 2024 | -2,006,393,700.00% |
| Jun 30, 2024 | -23,885.05% |
| Mar 31, 2024 | -10,285.34% |
| Dec 31, 2023 | -440,356,600.00% |
| Sep 30, 2023 | -5,993.38% |
| Jun 30, 2023 | -5,328.07% |
| Mar 31, 2023 | -7,307.62% |
| Dec 31, 2022 | -6,819.64% |
| Sep 30, 2022 | -61,899.59% |
| Jun 30, 2022 | -70,817.14% |
| Mar 31, 2022 | -10,081.46% |
| Dec 31, 2021 | -259,334.41% |
| Sep 30, 2021 | -1,361.22% |
API Access
Inhibikase Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();